Literature DB >> 25677323

Cholesterol crystals associate with coronary plaque vulnerability in vivo.

Yu Kataoka, Rishi Puri, Muhammad Hammadah, Bhanu Duggal, Kiyoko Uno, Samir R Kapadia, E Murat Tuzcu, Steven E Nissen, Stephen J Nicholls.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25677323     DOI： 10.1016/j.jacc.2014.11.039

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  21 in total

1.  Linear and planar reflection artifacts on swept-source and spectral-domain optical coherence tomography due to hyperreflective crystalline deposits.

Authors:  Serena Fragiotta; Pedro Fernández-Avellaneda; Mark P Breazzano; Lawrence A Yannuzzi; Christine A Curcio; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-26       Impact factor: 3.117

2.  Cholesterol crystal-induced coronary inflammation: Insights from optical coherence tomography and pericoronary adipose tissue computed tomography attenuation.

Authors:  Andrew Lin; Nitesh Nerlekar; Ravi Kiran Munnur; Yu Kataoka; Jordan Andrews; Damini Dey; Stephen J Nicholls; Dennis Tl Wong
Journal:  J Cardiovasc Comput Tomogr       Date:  2019-11-27

3.  Cholesterol crystals increase vascular permeability by inactivating SHP2 and disrupting adherens junctions.

Authors:  Arul M Mani; Rima Chattopadhyay; Nikhlesh K Singh; Gadiparthi N Rao
Journal:  Free Radic Biol Med       Date:  2018-05-19       Impact factor: 7.376

4.  Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis.

Authors:  Yu Kataoka; Stephen J Nicholls; Jordan Andrews; Kiyoko Uno; Samir R Kapadia; E Murat Tuzcu; Steven E Nissen; Rishi Puri
Journal:  Cardiovasc Diagn Ther       Date:  2022-02

Review 5.  Characterization of coronary atherosclerosis by intravascular imaging modalities.

Authors:  Satoshi Honda; Yu Kataoka; Tomoaki Kanaya; Teruo Noguchi; Hisao Ogawa; Satoshi Yasuda
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

6.  Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study.

Authors:  Stephen J Nicholls; Steven E Nissen; Francesco Prati; Stephan Windecker; Yu Kataoka; Rishi Puri; Thomas Hucko; Helina Kassahun; Jason Liao; Ransi Somaratne; Julie Butters; Giuseppe Di Giovanni; Stephen Jones; Peter J Psaltis
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

7.  Association between serum adipsin and plaque vulnerability determined by optical coherence tomography in patients with coronary artery disease.

Authors:  Renhua Sun; Yong Qiao; Gaoliang Yan; Dong Wang; Wenjie Zuo; Zhenjun Ji; Xiaoguo Zhang; Yuyu Yao; Genshan Ma; Chengchun Tang
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

8.  Optical coherence tomography for serial in vivo imaging of aortic plaque in the rabbit: a preliminary experience.

Authors:  Jordan Fulcher; Sanjay Patel; Stephen J Nicholls; Shisan Bao; David Celermajer
Journal:  Open Heart       Date:  2015-10-08

9.  Cholesterol crystal depth in coronary atherosclerotic plaques: A novel index of plaque vulnerability using optical frequency domain imaging.

Authors:  Masahiro Koide; Akiko Matsuo; Satoshi Shimoo; Kazuaki Takamatsu; Atsushi Kyodo; Yumika Tsuji; Kayoko Mera; Yoshinori Tsubakimoto; Koji Isodono; Tomohiko Sakatani; Keiji Inoue; Hiroshi Fujita
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

Review 10.  The Emerging Role of CT-Based Imaging in Adipose Tissue and Coronary Inflammation.

Authors:  Jeremy Yuvaraj; Kevin Cheng; Andrew Lin; Peter J Psaltis; Stephen J Nicholls; Dennis T L Wong
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.